[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 142
Correction
February 28, 2020

Errors in Abstract, Results, and Table 2

JAMA Netw Open. 2020;3(2):e201382. doi:10.1001/jamanetworkopen.2020.1382

In the Original Investigation titled “Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide,”1 published October 16, 2019, there were errors in the percentages of cases and controls exposed to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers shown in the Abstract, Results, and Table 2. Among cases, 27.0% were exposed to angiotensin receptor blockers, and 73.0% were exposed to angiotensin-converting enzyme inhibitors. Among controls, 19.2% were exposed to angiotensin receptor blockers, and 80.8% were exposed to angiotensin-converting enzyme inhibitors. This article has been corrected.1

References
1.
Mamdani  M, Gomes  T, Greaves  S,  et al.  Association between angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and suicide.  JAMA Netw Open. 2019;2(10):e1913304. doi:10.1001/jamanetworkopen.2019.13304PubMedGoogle Scholar
×